Advisory Board

Steven D. Averbuch, M.D.

• Vice President | Development Oncology and Pharmacodiagnostics for Bristol-Myers Squibb Company

John Fisher, M.D.

• Chief Executive Officer | Biopsy Sciences

Lili M. Portilla, MPA

• Director of Strategic Alliances | National Center for Advancing Translational Sciences (NCATS), NIH
• Board Member (ex-officio) | University Industry Demonstration Project of the National Archives

Michael Powell, Ph.D.

• General Partner | Sofinnova
• Adjunct Professor | University of Kansas Department of Pharmaceutical Chemistry

Michael D. Webb

• President and Chief Executive Officer | Allegro Diagnostics
• Chairman of the Board | Virtify

Thomas Wiggans

• Chief Executive Officer and Director | Dermira, Inc.
• Board member | Onyx Pharmaceuticals, Sangamo and Lithera

Last modified: Aug 13, 2015
IAMI Advisory Board duties

The IAMI Advisory Board is composed of six national leaders in medical innovation. The board:

provides insight and advocates for the discovery and development of medical innovations

provides expertise in reviewing and selecting projects

assists in developing a network of potential partners

provides philanthropic development support to target individual, corporate and foundation contributions for the sustainability of IAMI